T

Talmadge E. King

University of California, San Francisco

ORCID: 0000-0002-3526-2161

307 papers and 58.2k citations.

PubIndex Score91Top 9% · seniorHow it's scored

307Publications

58.2kTotal Citations

First publication: 1979First senior author: 1979

Top publicationsby citations

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

William D. Travis, Dominique Valeyre, James E. Loyd et al.|American Journal of Respiratory and Critical Care Medicine|2013

Cited by 4.3k

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Paul W. Noble, Roland M. du Bois, Carlo Albera et al.|The Lancet|2011

Cited by 2.1k

Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis

Harold R. Collard, Kevin K. Brown, Talmadge E. King et al.|American Journal of Respiratory and Critical Care Medicine|2003

Cited by 762

BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis

Talmadge E. King, Kevin M. Brown, Ganesh Raghu et al.|American Journal of Respiratory and Critical Care Medicine|2011

Cited by 713

A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis

Ganesh Raghu, Talmadge E. King, Kevin K. Brown et al.|New England Journal of Medicine|2004

Cited by 652

Indexing the rest of 307 publications…